PharmaVitae: Company Comparator Tool

Publication Date	February 2008
Publisher	Datamonitor
Product Type	Interactive Model
Pages	42
ISBN Number	not applicable
Product Code	DAT08410

Price

£22,800.00
approximately: $40,258 | €28,911

PDF

PRINT £22,850 ($40,346 | €28,974)

Order above formats by FAX

Summary

Introduction

The Comparator Tool builds from the PharmaVitae profiles of the 50 leading pharma companies. Updated monthly, the tool allows you to compare the 50 players by current and forecast sales to 2012.

Reasons to Purchase

Compare players by US or global forecast therapy area sales and portfolio breakdown measures to identify winners and losers over the next seven years Drill down to the individual drug forecast level for each company, identifying the key drivers behind forecast performance over the next seven years Access over 150,000 continuously tracked data points analyzing current and future trends in the pharmaceutical and biotech arenas.

Content

Overview
- This product contains forecasts for the leading 50 pharma companies-the PharmaVitae universe-across the seven major markets from 2007 to 2012. IT has been designed for delivery as an Excel Interactive Model, please download the Interactive Model to your desktop and open in Excel (as opposed to opening directly in Explorer). for more detail about the Comparator Tool, please see the accompanying PowerPoint slide pack
- Please select the Interactive Model option from the download menu at the right-hand side of the page to access the model, ensuring you download the model to your desktop then open in Excel
- in the event of technical difficulties, please also ensure that your version of Excel contains the latest service pack update from Microsoft: http://office.microsoft.com/downloads/default.aspx
- in the event of further technical issues, please contact PharmaVitae@datamonitor.com for assistance
- Introduction
- The Comparator Tool builds from the PharmaVitae profiles of the 50 leading pharma companies. Updated monthly, the tool allows you to compare the 50 players by current and forecast sales
- Key reasons to read this report
- Forecasting methodology
- The forecasting model
- Company-reported & analyst consensus data